latest news and updates

Science

Using multi-omics, our research decodes the exact biological mechanisms behind unexpected long-term survival.

Read More

spatial-biology-glioblastoma
Spatial biology is changing how we understand glioblastoma

Spatial biology is changing how we understand glioblastoma

population-diversity-clinical-trial-oncology
How Patient Diversity in Clinical Trials Improves Cancer Research

Patient Population diversity is essential to discovering the biology of exceptional cancer survival

promising-oncology-clinical-trials
Promising oncology clinical trials we're following closely

New cancer treatments: promising oncology clinical trials

exceptional-survivors-blueprint-defeat-cancer
Why do exceptional survivors hold the blueprint to defeating cancer?

We're turning the biology of exceptional cancer survivors into the next generation of cancer medicines

Dr-Deb-Schrafg-Oncology
What if improving cancer care started with listening more carefully to patients?

Patient perspective is the driving force behind our Rosalind Study

Science

Using multi-omics, our research decodes the exact biological mechanisms behind unexpected long-term survival.

Read More

spatial-biology-glioblastoma
Spatial biology is changing how we understand glioblastoma

Spatial biology is changing how we understand glioblastoma

population-diversity-clinical-trial-oncology
How Patient Diversity in Clinical Trials Improves Cancer Research

Patient Population diversity is essential to discovering the biology of exceptional cancer survival

promising-oncology-clinical-trials
Promising oncology clinical trials we're following closely

New cancer treatments: promising oncology clinical trials

exceptional-survivors-blueprint-defeat-cancer
Why do exceptional survivors hold the blueprint to defeating cancer?

We're turning the biology of exceptional cancer survivors into the next generation of cancer medicines

Dr-Deb-Schrafg-Oncology
What if improving cancer care started with listening more carefully to patients?

Patient perspective is the driving force behind our Rosalind Study

Science

Using multi-omics, our research decodes the exact biological mechanisms behind unexpected long-term survival.

Read More

spatial-biology-glioblastoma
Spatial biology is changing how we understand glioblastoma

Spatial biology is changing how we understand glioblastoma

population-diversity-clinical-trial-oncology
How Patient Diversity in Clinical Trials Improves Cancer Research

Patient Population diversity is essential to discovering the biology of exceptional cancer survival

promising-oncology-clinical-trials
Promising oncology clinical trials we're following closely

New cancer treatments: promising oncology clinical trials

exceptional-survivors-blueprint-defeat-cancer
Why do exceptional survivors hold the blueprint to defeating cancer?

We're turning the biology of exceptional cancer survivors into the next generation of cancer medicines

Dr-Deb-Schrafg-Oncology
What if improving cancer care started with listening more carefully to patients?

Patient perspective is the driving force behind our Rosalind Study

Cure51

Cure51 is a techbio company analyzing survival outliers to design next-generation cancer therapies.

Read More

marine-otero-del-val-chloe-monvoisin-nicolas-bonneau-cure51-product
Building a Product Ecosystem for Cancer Target Discovery

Cure51's product ecosystem connects multi-omics data, AI and scientific workflows to accelerate cancer target discovery

yann_bizien_science_illustrated
Our Patient Committee is a key part of our scientific approach

We work closely with exceptional survivors, clinicians, researchers and patient advocates across our international network

until-all-survive-website-for-cancer-patients
UntilAllSurvive.com: we're launching a new website for cancer patients!

UntilAllSurvive.com: a new website for cancer patients!

Emna-Makhlouf-Agathe-Lecaron-Ex-Vitro
Emna Makhlouf, Chief of Staff: "Working with cancer survivors gives a lot of purpose to what we do"

Emna Makhlouf, Chief of Staff, shares why our scientific approach feels positive

precision-medicine-nicolas-wolikow
Our CEO Nicolas Wolikow: "Turning precision medicine into an operational reality"

A fundamental shift: precision medicine is becoming actionable

Cure51

Cure51 is a techbio company analyzing survival outliers to design next-generation cancer therapies.

Read More

marine-otero-del-val-chloe-monvoisin-nicolas-bonneau-cure51-product
Building a Product Ecosystem for Cancer Target Discovery

Cure51's product ecosystem connects multi-omics data, AI and scientific workflows to accelerate cancer target discovery

yann_bizien_science_illustrated
Our Patient Committee is a key part of our scientific approach

We work closely with exceptional survivors, clinicians, researchers and patient advocates across our international network

until-all-survive-website-for-cancer-patients
UntilAllSurvive.com: we're launching a new website for cancer patients!

UntilAllSurvive.com: a new website for cancer patients!

Emna-Makhlouf-Agathe-Lecaron-Ex-Vitro
Emna Makhlouf, Chief of Staff: "Working with cancer survivors gives a lot of purpose to what we do"

Emna Makhlouf, Chief of Staff, shares why our scientific approach feels positive

precision-medicine-nicolas-wolikow
Our CEO Nicolas Wolikow: "Turning precision medicine into an operational reality"

A fundamental shift: precision medicine is becoming actionable

Cure51

Cure51 is a techbio company analyzing survival outliers to design next-generation cancer therapies.

Read More

marine-otero-del-val-chloe-monvoisin-nicolas-bonneau-cure51-product
Building a Product Ecosystem for Cancer Target Discovery

Cure51's product ecosystem connects multi-omics data, AI and scientific workflows to accelerate cancer target discovery

yann_bizien_science_illustrated
Our Patient Committee is a key part of our scientific approach

We work closely with exceptional survivors, clinicians, researchers and patient advocates across our international network

until-all-survive-website-for-cancer-patients
UntilAllSurvive.com: we're launching a new website for cancer patients!

UntilAllSurvive.com: a new website for cancer patients!

Emna-Makhlouf-Agathe-Lecaron-Ex-Vitro
Emna Makhlouf, Chief of Staff: "Working with cancer survivors gives a lot of purpose to what we do"

Emna Makhlouf, Chief of Staff, shares why our scientific approach feels positive

precision-medicine-nicolas-wolikow
Our CEO Nicolas Wolikow: "Turning precision medicine into an operational reality"

A fundamental shift: precision medicine is becoming actionable

Network

Connecting 50+ top oncology centers globally, this network drives international clinical data and sample sharing.

Read More

france-oncology-centers-cancer-research
Happy 14 Juillet! French oncology centers are an important part of our oncology network

Liberté, Égalité, Fraternité… and a shared commitment to advance cancer research

world-largest-clinical-oncology-network
New strategic partnerships: our global oncology network continues to expand!

Together, we're building the world's most comprehensive database of exceptional cancer survivors

CHUV-Centre-hospitalier-universitaire-vaudois
CHUV Lausanne received their Rosalind trophy!

Our partnership with CHUV plays a critical role in advancing our Rosalind Study

cure51-servier-paris-saclay-pscc-annual-event
Sharing Insights: our CEO Nicolas Wolikow Speaks at PSCC Annual Event!

Biotech startups and pharmaceutical companies can strengthen partnerships to accelerate drug development

Global-Cancer-Research-Compliance
How Cure51 Builds a Global Cancer Research Project Across 50+ Countries

Running an international oncology network across 50+ countries requires rigorous coordination and strict clinical research compliance

Network

Connecting 50+ top oncology centers globally, this network drives international clinical data and sample sharing.

Read More

france-oncology-centers-cancer-research
Happy 14 Juillet! French oncology centers are an important part of our oncology network

Liberté, Égalité, Fraternité… and a shared commitment to advance cancer research

world-largest-clinical-oncology-network
New strategic partnerships: our global oncology network continues to expand!

Together, we're building the world's most comprehensive database of exceptional cancer survivors

CHUV-Centre-hospitalier-universitaire-vaudois
CHUV Lausanne received their Rosalind trophy!

Our partnership with CHUV plays a critical role in advancing our Rosalind Study

cure51-servier-paris-saclay-pscc-annual-event
Sharing Insights: our CEO Nicolas Wolikow Speaks at PSCC Annual Event!

Biotech startups and pharmaceutical companies can strengthen partnerships to accelerate drug development

Global-Cancer-Research-Compliance
How Cure51 Builds a Global Cancer Research Project Across 50+ Countries

Running an international oncology network across 50+ countries requires rigorous coordination and strict clinical research compliance

Network

Connecting 50+ top oncology centers globally, this network drives international clinical data and sample sharing.

Read More

france-oncology-centers-cancer-research
Happy 14 Juillet! French oncology centers are an important part of our oncology network

Liberté, Égalité, Fraternité… and a shared commitment to advance cancer research

world-largest-clinical-oncology-network
New strategic partnerships: our global oncology network continues to expand!

Together, we're building the world's most comprehensive database of exceptional cancer survivors

CHUV-Centre-hospitalier-universitaire-vaudois
CHUV Lausanne received their Rosalind trophy!

Our partnership with CHUV plays a critical role in advancing our Rosalind Study

cure51-servier-paris-saclay-pscc-annual-event
Sharing Insights: our CEO Nicolas Wolikow Speaks at PSCC Annual Event!

Biotech startups and pharmaceutical companies can strengthen partnerships to accelerate drug development

Global-Cancer-Research-Compliance
How Cure51 Builds a Global Cancer Research Project Across 50+ Countries

Running an international oncology network across 50+ countries requires rigorous coordination and strict clinical research compliance

Patients

Centering on exceptional cancer survivors, this initiative highlights "outliers" who overcome aggressive prognoses.

Read More

cancer-survivors-inspiring-stories
UntilAllSurvive.com: where cancer survivors share their inspiring stories

UntilAllSurvive.com: our brand new website featuring captivating exceptional cancer survivor journeys

yann_bizien_science_illustrated
Our Patient Committee is a key part of our scientific approach

We work closely with exceptional survivors, clinicians, researchers and patient advocates across our international network

until-all-survive-website-for-cancer-patients
UntilAllSurvive.com: we're launching a new website for cancer patients!

UntilAllSurvive.com: a new website for cancer patients!

Dr-Deb-Schrafg-Oncology
What if improving cancer care started with listening more carefully to patients?

Patient perspective is the driving force behind our Rosalind Study

pancreatic-cancer-patient-advocacy
Advancing Cancer Research Through Patient Advocacy

Working hand in hand with patient advocates to advance Pancreatic Cancer Research

Patients

Centering on exceptional cancer survivors, this initiative highlights "outliers" who overcome aggressive prognoses.

Read More

cancer-survivors-inspiring-stories
UntilAllSurvive.com: where cancer survivors share their inspiring stories

UntilAllSurvive.com: our brand new website featuring captivating exceptional cancer survivor journeys

yann_bizien_science_illustrated
Our Patient Committee is a key part of our scientific approach

We work closely with exceptional survivors, clinicians, researchers and patient advocates across our international network

until-all-survive-website-for-cancer-patients
UntilAllSurvive.com: we're launching a new website for cancer patients!

UntilAllSurvive.com: a new website for cancer patients!

Dr-Deb-Schrafg-Oncology
What if improving cancer care started with listening more carefully to patients?

Patient perspective is the driving force behind our Rosalind Study

pancreatic-cancer-patient-advocacy
Advancing Cancer Research Through Patient Advocacy

Working hand in hand with patient advocates to advance Pancreatic Cancer Research

Patients

Centering on exceptional cancer survivors, this initiative highlights "outliers" who overcome aggressive prognoses.

Read More

cancer-survivors-inspiring-stories
UntilAllSurvive.com: where cancer survivors share their inspiring stories

UntilAllSurvive.com: our brand new website featuring captivating exceptional cancer survivor journeys

yann_bizien_science_illustrated
Our Patient Committee is a key part of our scientific approach

We work closely with exceptional survivors, clinicians, researchers and patient advocates across our international network

until-all-survive-website-for-cancer-patients
UntilAllSurvive.com: we're launching a new website for cancer patients!

UntilAllSurvive.com: a new website for cancer patients!

Dr-Deb-Schrafg-Oncology
What if improving cancer care started with listening more carefully to patients?

Patient perspective is the driving force behind our Rosalind Study

pancreatic-cancer-patient-advocacy
Advancing Cancer Research Through Patient Advocacy

Working hand in hand with patient advocates to advance Pancreatic Cancer Research

Rosalind Study

Cure51’s flagship study compares long-term survivors with matched controls to uncover new drug targets.

Read More

population-diversity-clinical-trial-oncology
How Patient Diversity in Clinical Trials Improves Cancer Research

Patient Population diversity is essential to discovering the biology of exceptional cancer survival

france-oncology-centers-cancer-research
Happy 14 Juillet! French oncology centers are an important part of our oncology network

Liberté, Égalité, Fraternité… and a shared commitment to advance cancer research

exceptional-survivors-blueprint-defeat-cancer
Why do exceptional survivors hold the blueprint to defeating cancer?

We're turning the biology of exceptional cancer survivors into the next generation of cancer medicines

Dr-Deb-Schrafg-Oncology
What if improving cancer care started with listening more carefully to patients?

Patient perspective is the driving force behind our Rosalind Study

world-largest-clinical-oncology-network
New strategic partnerships: our global oncology network continues to expand!

Together, we're building the world's most comprehensive database of exceptional cancer survivors

Rosalind Study

Cure51’s flagship study compares long-term survivors with matched controls to uncover new drug targets.

Read More

population-diversity-clinical-trial-oncology
How Patient Diversity in Clinical Trials Improves Cancer Research

Patient Population diversity is essential to discovering the biology of exceptional cancer survival

france-oncology-centers-cancer-research
Happy 14 Juillet! French oncology centers are an important part of our oncology network

Liberté, Égalité, Fraternité… and a shared commitment to advance cancer research

exceptional-survivors-blueprint-defeat-cancer
Why do exceptional survivors hold the blueprint to defeating cancer?

We're turning the biology of exceptional cancer survivors into the next generation of cancer medicines

Dr-Deb-Schrafg-Oncology
What if improving cancer care started with listening more carefully to patients?

Patient perspective is the driving force behind our Rosalind Study

world-largest-clinical-oncology-network
New strategic partnerships: our global oncology network continues to expand!

Together, we're building the world's most comprehensive database of exceptional cancer survivors

Rosalind Study

Cure51’s flagship study compares long-term survivors with matched controls to uncover new drug targets.

Read More

population-diversity-clinical-trial-oncology
How Patient Diversity in Clinical Trials Improves Cancer Research

Patient Population diversity is essential to discovering the biology of exceptional cancer survival

france-oncology-centers-cancer-research
Happy 14 Juillet! French oncology centers are an important part of our oncology network

Liberté, Égalité, Fraternité… and a shared commitment to advance cancer research

exceptional-survivors-blueprint-defeat-cancer
Why do exceptional survivors hold the blueprint to defeating cancer?

We're turning the biology of exceptional cancer survivors into the next generation of cancer medicines

Dr-Deb-Schrafg-Oncology
What if improving cancer care started with listening more carefully to patients?

Patient perspective is the driving force behind our Rosalind Study

world-largest-clinical-oncology-network
New strategic partnerships: our global oncology network continues to expand!

Together, we're building the world's most comprehensive database of exceptional cancer survivors

Join us to eradicate Cancer.

Join us to eradicate Cancer.

Join us to eradicate Cancer.

Join us to eradicate Cancer.

Follow us

Linkedin

Facebook

Instagram

Contact us

Contact us

Follow us

Linkedin

Facebook

Instagram

Contact us

ROSALIND

Contact us